Sage Therapeutics, Inc. (SAGE)

Sage Therapeutics Statistics

Total Valuation

SAGE has a market cap or net worth of $343.18 million. The enterprise value is -$215.70 million.

Market Cap	343.18M
Enterprise Value	-215.70M

Important Dates

The next estimated earnings date is Wednesday, February 12, 2025, before market open.

Earnings Date	Feb 12, 2025
Ex-Dividend Date	n/a

Share Statistics

SAGE has 61.17 million shares outstanding. The number of shares has increased by 1.23% in one year.

Current Share Class	61.17M
Shares Outstanding	61.17M
Shares Change (YoY)	+1.23%
Shares Change (QoQ)	+0.96%
Owned by Insiders (%)	1.62%
Owned by Institutions (%)	75.98%
Float	48.35M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.19
Forward PS	4.94
PB Ratio	0.62
P/TBV Ratio	0.62
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.02, with a Debt / Equity ratio of 0.02.

Current Ratio	10.02
Quick Ratio	9.72
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -49.34% and return on invested capital (ROIC) is -33.60%.

Return on Equity (ROE)	-49.34%
Return on Assets (ROA)	-29.62%
Return on Capital (ROIC)	-33.60%
Revenue Per Employee	$218,478
Profits Per Employee	-$693,211
Employee Count	487
Asset Turnover	0.14
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -74.75% in the last 52 weeks. The beta is 0.93, so SAGE's price volatility has been similar to the market average.

Beta (5Y)	0.93
52-Week Price Change	-74.75%
50-Day Moving Average	6.09
200-Day Moving Average	10.24
Relative Strength Index (RSI)	50.27
Average Volume (20 Days)	1,134,025

Short Selling Information

The latest short interest is 6.53 million, so 10.67% of the outstanding shares have been sold short.

Short Interest	6.53M
Short Previous Month	6.41M
Short % of Shares Out	10.67%
Short % of Float	13.50%
Short Ratio (days to cover)	7.21

Income Statement

In the last 12 months, SAGE had revenue of $106.40 million and -$337.59 million in losses. Loss per share was -$5.59.

Revenue	106.40M
Gross Profit	-159.16M
Operating Income	-372.46M
Pretax Income	-445.67M
Net Income	-337.59M
EBITDA	-371.15M
EBIT	-372.46M
Loss Per Share	-$5.59

Balance Sheet

The company has $569.15 million in cash and $10.27 million in debt, giving a net cash position of $558.88 million or $9.14 per share.

Cash & Cash Equivalents	569.15M
Total Debt	10.27M
Net Cash	558.88M
Net Cash Per Share	$9.14
Equity (Book Value)	551.84M
Book Value Per Share	9.02
Working Capital	544.58M

Cash Flow

In the last 12 months, operating cash flow was -$320.15 million and capital expenditures $112,000, giving a free cash flow of -$320.04 million.

Operating Cash Flow	-320.15M
Capital Expenditures	112,000
Free Cash Flow	-320.04M
FCF Per Share	-$5.23

Margins

Gross Margin	-149.58%
Operating Margin	-350.06%
Pretax Margin	-317.29%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SAGE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.23%
Shareholder Yield	-1.23%
Earnings Yield	-98.37%
FCF Yield	-93.26%

Analyst Forecast

The average price target for SAGE is $11.53, which is 105.53% higher than the current price. The consensus rating is "Hold".

Price Target	$11.53
Price Target Difference	105.53%
Analyst Consensus	Hold
Analyst Count	19
Revenue Growth Forecast (5Y)	31.08%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SAGE has an Altman Z-Score of 1.02 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.02
Piotroski F-Score	4